Vaccination of high-risk patients against influenza: Impact on primary care contact rates during epidemics: Analysis of routinely collected data

Vaccine

Volumn 22, Issue 23-24, 2004, Pages 2985-2992

  Tacken, M A J B ^a   Braspenning, J C C ^a   Berende, A ^a   Hak, E ^b   De Bakker, D H ^c   Groenewegen, P P ^c   Grol, R P T M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Contact rate; Influenza vaccination; Primary care

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; EPIDEMIC; FEMALE; GENERAL PRACTITIONER; HIGH RISK POPULATION; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; DATA COLLECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, STATISTICAL; NETHERLANDS; ODDS RATIO; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; RISK;

EID: 3843103724     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.02.017     Document Type: Article

References (36)

1. van Essen G.A., Kuyvenhoven M.M., de Melker R.A. Implementing the Dutch College of General Practitioners' guidelines for influenza vaccination: an intervention study. Br. J. Gen. Pract. 47(414):1997;25-29
2. Hak E., Nordin J., Wei F., Mullooly J., Poblete S., Strikas R., et al. Influence of high risk medical conditions on the effectiveness of influenza vaccination among elderly members of three large managed care organizations. Clin. Infect. Dis. 35:2002;370-377
3. Hak E., Hoes A.W., Verheij T.J.M. Influenza vaccination: who needs them and when? Drugs. 62:2002;2413-2420
4. Nichol K.L., Goodman M. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. Pharmaco Econ. 16(Suppl. 1):1999;63-71
5. Couch R.B. Prevention and treatment of influenza. N. Engl. J. Med. 343:2000;1778-1787
6. Innes A., Beresford E., Bedford J. Influenza vaccination in asthma: a primary care experience. Br. J. Gen. Pract. 50(450):2000;27-30
7. Cifu A., Levinson W. Linking evidence and experience; influenza. JAMA. 284(22):2000;2847-2849
8. Tacken M., Braspenning J., Spreeuwenberg P., van den Hoogen H., van Essen G., de Bakker D., et al. Patient characteristics determine differences in the influenza vaccination rate more so than practice features. Prev. Med. 35:2002;401-406. doi: 10.1006/pmed.2002.1083
9. Uphoff H., Cohen J.M. Some aspects regarding the interpretation of influenza surveillance data. Med. Microbiol. Immunol. 191:2002;145-149. doi 10.1007/s00430-002-0135-0
10. Gross P.A., Hermogenes A.W., Sacks H.S., Lau J., Levandowski R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Intern. Med. 123:1995;518-527
11. Ohmit S.E., Monto A.S. Influenza vaccine effectiveness in preventing hospitalization for pneumonia among the elderly during influenza A and type B seasons. Int. J. Epidemiol. 24:1995;1240-1248
12. Flemming D.M., Watson J.M., Nicholas S., et al. Study on the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-1990 using a general practice database. Epidemiol. Infect. 115:1995;581-589
13. Lui K.J., Kendal A.P. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health. 77:1987;712-716
14. Nichol K.L., Nordin J., Mullooly J., Lask R., Fillbrandt K., Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N. Engl. J. Med. 348(14):2003;1322-1332
15. Glaser WA. Paying the doctor: systems of remuneration and their effects. Baltimore: Johns Hopkins Press; 1970.
16. Hak E., Hermens R.P.M.G., Hoes A.W., Verheij Th.J.M., Kuyvenhoven M.M., Essen van G.A. Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands. Scand. J. Prim Health Care. 18:2000;237-241
17. van Essen G.A., Sorgedrager Y.C.G., Salemink G.W., Govaert T.h.M.E., van den Hoogen J.P.H., van der Laan J.R. NHG-standaard influenza en influenzavaccinatie [Dutch College of General Practitioners guideline on influenza and influenza vaccination]. Huisarts Wet. 36(10):1993;342-346. [with summary in English]
18. Hak E., van Essen G.A., Stalman W., de Melker R. Improving influenza vaccination coverage among high-risk patients: a role for computer-supported prevention strategy? Fam. Pract. 15(2):1998;138-143
19. Rimmelzwaan G.F., de Jong J.C., Bartelds A.I., Dorigo-Zetsma J.W., Fouchier R.A., Osterhaus A.D. The influenza season 1999/2000 and vaccine composition for the season 2000/2001. Ned. Tijdschr. Geneeskd. 144(41):2000;1968-1971
20. Rimmelzwaan G.F., de Jong J.C., Bartelds A.I., Wilbrink B., Fouchier R.A., Osterhaus A.D. The 2001/2002 influenza season and the vaccine composition for the 2002/2003 season. Ned. Tijdschr. Geneeskd. 146(39):2002;1846-1850
21. Bartelds A. Continuous morbidity registration at Dutch sentinel statins in 2000. Utrecht: Netherlands Institute for Health Services Research (NIVEL); 2002.
22. Chapman G.B., Coups E.J. Predictors of influenza vaccine acceptance among healthy adults. Prev. Med. 29(4):1999;249-262. doi: 10.1006/pmed.1999.0535
23. Van Essen G.A., Kuyvenhoven M.M., De Melker R.A. Compliance with influenza vaccination. Its relation with epidemiologic and sociopsychological factors. Arch. Fam. Med. 6(2):1997;157-163
24. Rubin D. Estimating causal effects from large data sets using propensity scores. Ann. Intern. Med. 127(8 (pt 2)):1997;757-763
25. Drake C., Fisher L. Prognostic models and the propensity score. Int. J. Epidemiol. 24(1):1995;183-187
26. Bratzler D.W., Houck P.M., Jiang H., Nsa W., Shook C., Moore L., et al. Failure to vaccinate Medicare inpatients: a missed opportunity. Arch. Intern. Med. 162(20):2002;2349-2356
27. Naghavi M., Barlas Z., Siadaty S., Naguib S., Madjid M., Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 102(25):2000;3039-3045
28. Tacken M., Braspenning J., van Paassen J., van den Hoogen H., de Bakker D., Grol R. Negen jaar influenzavaccinatie in de huisartspraktijk [Nine years of influenza vaccination in general practice]. Huisarts Wet. 43(13):2000;566-567
29. Vlug A.E., van der Lei J., Mosseveld B.M.Th., van Wijk M.A.M., van der Linden P.D., Sturkenboom M.C.J.M., et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inform. Med. 38:1999;339-344
30. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the united states. JAMA. 289:2003;179-186
31. Monto A.S. Invited commentary: use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza efficacy. Am. J. Epidemiol. 158:2003;312-315
32. Govaert Th.M.E., Dinant G.J., Aretz K., Knottnerus J.A. The predictive value of influenza sympotmatology in elderly people. Fam. Pract. 15(1):1998;16-22
33. Drenthen T. Challenges to prevention in Dutch general practice. Am. J. Clin. Nutr. 65(Suppl. 6):1997;S1943-S1945
34. Bruce N., Burnett S. Prevention of lifestyle-related disease: general practitioners' views about their role, effectiveness and resources. Fam. Pract. 8(4):1991;373-377
35. Bartelds A. Continuous morbidity registration at Dutch sentinel stations. Utrecht: Netherlands Institute for Health Services Research (NIVEL); 1991.
36. Bartelds A. Continuous morbidity registration at Dutch sentinel stations. Utrecht: Netherlands Institute for General Practice (NHI); 1981.